Diagnosis and treatment of primary signet-ring cell carcinoma of the prostate.
Lilleby
Wolfgang
W
Axcrona
Karol
K
Alfsen
G Cecilie
GC
Urnes
Thomas
T
Hole
Knut H
KH
D000359:Aftercare; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D018279:Carcinoma, Signet Ring Cell / Q000175:diagnosis* / Q000628:therapy*; D003131:Combined Modality Therapy; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy; D009376:Neoplasms, Hormone-Dependent / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D020266:Radiotherapy, Conformal
D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin